We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. FDA Bans Drugs From India’s Polydrug Labs, Citing GMP Issues
U.S. FDA Bans Drugs From India’s Polydrug Labs, Citing GMP Issues
The U.S. Food and Drug Administration has banned imports of drugs made at Mumbai, India-based Polydrug Laboratories, marking the latest development in ongoing issues involving Indian manufacturers.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor